Literature DB >> 25287049

Are teleoncology models merely about avoiding long distance travel for patients?

S Sabesan1, J Kelly.   

Abstract

Teleoncology models are used increasingly throughout the world as a means to provide access to quality cancer care for people in rural, remote and other disadvantaged settings. Some authors have suggested that teleoncology is merely about avoiding long distance travel. In this commentary we argue that the benefits of teleoncology extend beyond those of the patients and their families to the rural health system and beyond. We draw upon the literature and results of an evaluation of the Townsville Teleoncology Network (TTN) in North Queensland, Australia to support our arguments.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  cancer care; oncological outcome; policy; rural; telemedicine

Mesh:

Year:  2014        PMID: 25287049     DOI: 10.1111/ecc.12251

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  3 in total

1.  Variations in outcomes by residential location for women with breast cancer: a systematic review.

Authors:  Paramita Dasgupta; Peter D Baade; Danny R Youlden; Gail Garvey; Joanne F Aitken; Isabella Wallington; Jennifer Chynoweth; Helen Zorbas; Philippa H Youl
Journal:  BMJ Open       Date:  2018-04-29       Impact factor: 2.692

2.  Clinicians' Perceptions of the Benefits and Challenges of Teleoncology as Experienced Through the COVID-19 Pandemic: Qualitative Study.

Authors:  Jordan M Alpert; Greenberry Taylor; Chelsea N Hampton; Samantha Paige; Merry Jennifer Markham; Carma L Bylund
Journal:  JMIR Cancer       Date:  2022-02-24

3.  Geographical Inequalities in Surgical Treatment for Localized Female Breast Cancer, Queensland, Australia 1997-2011: Improvements over Time but Inequalities Remain.

Authors:  Peter D Baade; Paramita Dasgupta; Philippa H Youl; Christopher Pyke; Joanne F Aitken
Journal:  Int J Environ Res Public Health       Date:  2016-07-19       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.